Strategic Initiative

Slingshot members are tracking this corporate initiative:

Regeneron and Sanofi To Accelerate and Expand Investment for Cemiplimab and Dupilumab Development Programs

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks



Additional Information

Additional Relevant Details Under the terms of the expansion, the investment in cemiplimab will be increased to a minimum of $1.64 billion, an increase of approximately $1 billion over the initial 2015 agreement, and Sanofi and Regeneron will continue to equally fund cemiplimab development. 
Slingshot Insights Explained
Strategic Initiative Date
Announcement Date:
Jan 08, 2018
Projected Implementation:
Q1, 2018
Relevance Tracked Until:
Q3, 2018
Related Projects Image
  • Don’t see a project related to the strategic initiative you care about?

Related Keywords Cemiplimab, Dupilumab, Pd-1